Literature DB >> 26572400

Nanofiller for the mechanical reinforcement of maltodextrins orodispersible films.

Ilaria Franceschini1, Francesca Selmin2, Stefania Pagani3, Paola Minghetti4, Francesco Cilurzo5.   

Abstract

One of the most critical quality attributes of orodispersible films (ODFs) is related to the development of dosage forms with tensile properties suitable for the packaging and patient's handling. Aiming to develop a strategy to reinforce the tensile properties, the current work reported the feasibility to improve the tensile strength of maltodextrins (MDX) based ODFs by adding an amorphous water insoluble nanofiller, namely polyvinylacetate (PVAc). The possible interactions between components investigated by DSC and ATR-FTIR spectroscopy revealed that MDX and PVAc were immiscible; even if, the presence of plasticizers permitted the homogeneous dispersion of PVAc in the film until the 10% w/w concentration was reached. As a consequence, PVAc nanoparticles was found to be an effective reinforcing agent only at the concentrations of 3 and 5% w/w. In this optimal range, the tensile strength increased at least 1.5 fold and the elastic modulus increased at least 4 times.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Casting solution; Maltodextrins; Mechanical reinforcement; Nanofiller; Orodispersible films; Tensile properties

Mesh:

Substances:

Year:  2015        PMID: 26572400     DOI: 10.1016/j.carbpol.2015.09.077

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  2 in total

1.  Control of Drug Dissolution Rate from Film Dosage Forms Containing Valsartan.

Authors:  Yoshifumi Murata; Kyoko Kofuji; Chieko Maida
Journal:  Int Sch Res Notices       Date:  2016-05-23

Review 2.  Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence.

Authors:  Enrica Menditto; Valentina Orlando; Giuseppe De Rosa; Paola Minghetti; Umberto Maria Musazzi; Caitriona Cahir; Marta Kurczewska-Michalak; Przemysław Kardas; Elísio Costa; José Manuel Sousa Lobo; Isabel F Almeida
Journal:  Pharmaceutics       Date:  2020-01-03       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.